Access & pricing

Integrating insights and evidence to achieve optimal market access

Accelerate patient access to optimal healthcare through US and global market access and pricing strategies validated by the world's largest pre-vetted network of payers and KOLs, and reinforced by market access analytics.

market access evidence generation for biopharma

Our market access and pricing consulting services include:

RPR stakeholder engagement platform
HTA landscapes
Disease landscapes
Pricing and reimbursement landscape
Contracting/formulary decisions landscape
Horizon scanning
Briefing or strategic playbooks
Target product profile (TPP) development and optimization
Value message development
Payer value proposition and hypothesis testing

Objection handlers
Value dossiers
Stakeholder mapping
Payer segmentation
Therapy benchmarking/minimum required magnitude of benefit
Advisory boards
Strategy workshops
Market access concept workshop with payers (e.g. IRA)
Pricing strategy
Innovative contracting strategy

Arrange a meeting

Strategy. Insights. Access.

Discover our integrated, data-driven solutions for US and global access and pricing.

In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision.

We leverage our proprietary RPR stakeholder engagement platform, a network of 3,500+ vetted payers, clinicians, and KOLs across 65 countries, coupled with deep expertise in access, pricing, HEOR, and real-world analytics, to deliver end-to-end solutions that drive commercial success.

Our capabilities can be seamlessly integrated or applied independently—helping you transform complex challenges and gain a tangible competitive advantage throughout the product lifecycle.

Global strategic advisory

Navigate complex US and global challenges with clarity and confidence. Our experts partner with you to develop detailed strategies on product positioning, pricing, and value demonstration – maximizing commercial success through tailored, market-specific solutions.

Pricing strategy and analysis

We help you set and optimize the price of your product, considering the market dynamics, payer expectations, competitor activities, and regulatory requirements, and by assessing the impact of different pricing scenarios on your revenue and profitability.

RPR stakeholder insights

Empower strategic access and pricing decisions with RPR, our proprietary stakeholder engagement platform. Gain actionable and pressure-tested insights from 3,500+ vetted payers, clinicians, and KOLs across 65 countries – delivered faster and more robustly than traditional primary research methods.

Analogue and landscape research

Our tailored secondary research delivers precise benchmarking on pricing, reimbursement decisions, and HTA outcomes – seamlessly integrated with access and pricing, HEOR, and evidence generation expertise to reduce uncertainty and inform effective decision-making.

A&P Flexible Integrated Teams (FIT)

Benefit from adaptable contracting models tailored to your specific needs, or build an agile, extended partnership with our innovative Access & Pricing FIT (Flexible Integrated Team) for long-term strategic collaboration.

3500

stakeholders

countries

weeks to insights

Secure robust insights with our unique stakeholder engagement platform

Direct stakeholder engagement is critical when assessing your access and pricing strategy, insights, and messaging. Supported by our experts, our online RPR platform leverages a global network of 3,500+ vetted stakeholders across 65+ countries to secure robust insights in a fraction of the time and cost of a traditional approach.

Boosted
relevance

The RPR platform integrates real-world insights from decision-makers, enriching research findings and bridging data gaps to align with research goals.

Enhanced
accuracy

RPR not only fills research gaps but also refines insight. For instance, while secondary research might hint at a need for more RWE, RPR pinpoints the methodologies and outcomes acceptable to payers.

Superior
validity

RPR dives deeper than traditional research, sourcing data directly from key audiences, including payers, physicians, KOLs, and patient advocacy groups.

Strategic
decision-making

Manufacturers can fine-tune their market access and pricing strategies with RPR, enabling precise decision-making and clear identification of both risks and opportunities.

Learn more about an RPR-powered approach

About RPR

A global, vetted stakeholder network

3500+ experts across 65 countries are ready to provide the answers and clarifications you need

We search the globe for the most reputable experts before vetting them for suitability through a rigorous quality assurance and testing procedure. Each expert is tagged and classified according to their area of expertise and location, so that we can match the right experts to the right research objectives for our clients.

If you are an experienced healthcare decision-maker/stakeholder interested in helping to optimize patient outcomes, we invite you to consider sharing your expertise via our online survey platform, providing input when your schedule allows and being remunerated for your time.

Join our network

Accelerated Insight Generation

Where technology meets market access expertise

Supported by specialist teams, our suite of agile technology platforms allows us to provide clients with enhanced pricing and market access services by delivering impactful insights at an accelerated rate.

Our RPR platform can be employed to integrate stakeholder insights into any aspect of product development and commercialization. EVID AI enhances and accelerates literature reviews; Dashboards leverage data visualization techniques to transform and extrapolate value from complex data into communicable insights; and our Integrated Evidence Planning platforms meet the challenge of evidence organization and communication.

Explore our technology

It’s in our DNA. Discover your new strategic partner

Our strategic consulting framework provides a clear path from evidence to impact. We can provide you with a robust framework for strategic thinking, unbiased perspectives, clear next steps/rationale, and confidence in your decision-making.

Explore our DNA! Download our brochure

Shining the light on vaccine market access

A World EPA Congress 2024 presentation with Katrin Nather, PhD, Associate Director, and Tijana Ignjatovic, Executive Director, Genesis Research Group.

With more and more innovative vaccines and immunization strategies coming to the market, there is an increasing drive for understanding the key decision drivers for vaccine market access. However, the overall decision-making processes across markets are often ill-defined.

Through our proprietary RPR platform, we have engaged with key decision stakeholders in vaccine market access to ‘shine a light’ on key decision criteria and access processes for vaccines in order to evaluate the opportunities of novel vaccines and guide strategic market access decisions.

Ask a question or request slides

Flexible Integrated Teams (FIT)

Market access research partnerships reimagined

Your access and pricing needs can be met through our optional FIT engagement model, an innovative approach which provides tailored, cross-functional RWE, HEOR, and market access teams that integrate seamlessly within your own to fill experience gaps or supplement existing resources.

The size and composition of your team can gradually evolve or pivot quickly to meet your changing needs, all without the costly delays involved in adjusting a statement of work.

A trusted extension of your organization, our team becomes your team.

Learn more

How to respond to the EU Joint Clinical Assessment (JCA).

Download our brochure

Selected access and pricing publications

Our teams have co-authored over 1000 publications across the full range of therapeutic areas, data sources, indications, and methods. A selection of our recent access and pricing related publications can be found below. For a wider list, please visit our publications directory.

Title	GR Author(s)	Year	Therapeutic Area	Data Source	Journal/Conference	Full Citation & Links
Assessment of the relevance and credibility of indirect treatment comparisons to help inform health technology assessment and reimbursement decision-making: results of a 5-country payer survey.	Katsoulis I, Graham A	2023	General Medicine	RPR Survey	ISPOR Europe	View
Paradigm Shift or Incremental Change? Real-World Evidence for Health Technology Assessment in Oncology.	Ignjatovic T	2023	Oncology	RPR Survey	ISPOR Europe	View

View our full publication list

Genesis Research Hub

Publications

Explore our publications for details of our peer-reviewed research and therapeutic experience.

Insights

Delve deeper into Genesis Research: videos, interviews, papers, webinars, and case studies.

News & Events

Check out our latest news and events. We hope to see you soon at an upcoming show or webinar!

Case studies

How our approach, expertise, and research capabilities have impacted upon our clients' success.

Keep current on the latest research and learn more about our work by signing up to our newsletter.

Genesis Research Group - ISPOR corporate partner

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US